Retraction to Effects of ceftriaxone on systemic and central expression of anti- and pro-inflammatory cytokines in alcohol-preferring (P) rats exposed to ethanol [Alcohol and Alcoholism, 49, 4, (2014), 390-398] DOI:10.1093/alcalc/agu019;Effects of ceftriaxone on systemic and central expression of anti- and pro-inflammatory cytokines in alcohol-preferring (P) rats exposed to ethanol

Alcohol and Alcoholism

Volumn 49, Issue 4, 2014, Pages 390-398

  Rao, P S S ^a   Ahmed, S ^a   Sari, Y ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CEFTRIAXONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; SODIUM GLUCOSE COTRANSPORTER 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN TISSUE; CONTROLLED STUDY; FLUID INTAKE; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

EID: 84902506743     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agu071     Document Type: Erratum

References (53)

1. Alho H, Sillanaukee P, Kalela A et al. (2004) Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein. Alcohol Alcohol 39:312-5.
2. Amin B, Hajhashemi V, Hosseinzadeh H et al. (2012) Antinociceptive evaluation of ceftriaxone and minocycline alone and in combination in a neuropathic pain model in rat. Neuroscience 224:15-25.
3. An L, Wang X, Cederbaum AI (2012) Cytokines in alcoholic liver disease. Arch Toxicol 86:1337-48.
4. Bala S, Marcos M, Kodys K et al. (2011) Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem286:1436-44.
5. Banchereau J, Pascual V, O'Garra A. (2012) From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 13:925-31.
6. Bell RL, Rodd ZA, Lumeng L et al. (2006a) The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol 11:270-88.
7. Bell RL, Rodd ZA, Sable HJ et al. (2006b) Daily patterns of ethanol drinking in peri-adolescent and adult alcohol-preferring (P) rats. Pharmacol Biochem Behav 83:35-46.
8. Bussolati B, Mariano F, Montrucchio G et al. (1997) Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. Immunology 90:440-7.
9. Carey AJ, Tan CK, Ulett GC. (2012) Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes. JAKSTAT 1:159-67.
10. Chen J, Liu X. (2009) The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications. Cell Immunol 254:85-90.
11. Chen SL, Tao PL, Chu CH et al. (2012) Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol 7:444-53.
12. Dada LA, Sznajder JI. (2011) Mitochondrial Ca(2)+ and ROS take center stage to orchestrate TNF-alpha-mediated inflammatory responses. J Clin Invest 121:1683-5.
13. Dang PM, Elbim C, Marie JC et al. (2006) Anti-inflammatory effect of interleukin-10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB J 20:1504-6.
14. de Waal Malefyt R, Abrams J, Bennett B et al. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-20.
15. Fischer KD, Houston AC, Rebec GV. (2013) Role of the major glutamate transporter GLT1 in nucleus accumbens core versus shell in cue-induced cocaine-seeking behavior. J Neurosci 33:9319-27.
16. Fox C, Dingman A, Derugin N et al. (2005) Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 25:1138-49.
17. Fuchs AC, Granowitz EV, Shapiro L et al. (1996) Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J Clin Immunol 16:291-303.
18. Hill DB, D'Souza NB, Lee EY et al. (2002) A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26:74-82.
19. Iimuro Y, Gallucci RM, Luster MI et al. (1997) Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26:1530-7.
20. Imhof A, Froehlich M, Brenner H et al. (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357:763-7.
21. Iyer SS, Cheng G. (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32:23-63.
22. Jackman NA, Uliasz TF, Hewett JA et al. (2010) Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1beta: implications for hypoxic neuronal injury. Glia 58:1806-15.
23. Kahraman A, Cakar H, Koken T. (2012) The protective effect of quercetin on long-term alcohol consumption-induced oxidative stress. Mol Biol Rep 39:2789-94.
24. Knackstedt LA, Melendez RI, Kalivas PW. (2010) Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 67:81-4.
25. Li MO, Flavell RA. (2008) Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28:468-76.
26. McBride WJ, Rodd ZA, Bell RL et al. (2014) The alcohol-preferring (P) and high-alcohol-drinking (HAD) rats -Animal models of alcoholism. Alcohol, in press.
27. McClain CJ, Shedlofsky S, Barve S et al. (1997) Cytokines and alcoholic liver disease. Alcohol Health Res World 21:317-20.
28. McClain CJ, Barve S, Deaciuc I et al. (1998) Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res 22:248S-52S.
29. Miller AM, Horiguchi N, Jeong WI et al. (2011) Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res 35:787-93.
30. Moore KW, de Waal Malefyt R, Coffman RL et al. (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
31. Murphy JM, Gatto GJ, Waller MB et al. (1986) Effects of scheduled access on ethanol intake by the alcohol-preferring (P) line of rats. Alcohol 3:331-6.
32. Nanji AA, Jokelainen K, Rahemtulla A et al. (1999) Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30:934-43.
33. O'Garra A, Vieira P. (2007) T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7:425-8.
34. Paxinos G, Watson C. (2007) The Rat Brain in Stereotaxic Coordinates. Sixth Edition. New York: Academic Press.
35. Qin L, Crews FT. (2012) Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration. J Neuroinflammation 9:130.
36. Qin L, He J, Hanes RN et al. (2008) Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 5:10.
37. Qrunfleh AM, Alazizi A, Sari Y. (2013) Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats. J Psychopharmacol 27:541-9.
38. Rao PS, Sari Y. (2014) Effects of Ceftriaxone on Chronic Ethanol Consumption: a Potential Role for xCT and GLT1 Modulation of Glutamate Levels in Male P Rats. J Mol Neurosci, in press.
39. Rasmussen BA, Baron DA, Kim JK et al. (2011) beta-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids 40:761-4.
40. Rawls SM, Cavallo F, Capasso A et al. (2008) The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinenceinduced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians. Eur J Pharmacol 584:278-84.
41. Rossi S, Furlan R, De Chiara V et al. (2012) Interleukin-1beta causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol 71:76-83.
42. Santucci L, Fiorucci S, Chiorean M et al. (1996) Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology 111:736-44.
43. Saraiva M, O'Garra A. (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-81.
44. Sari Y, Sreemantula SN. (2012) Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats. Neuroscience 227:327-35.
45. Sari Y, Sakai M, Weedman JM et al. (2011) Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 46:239-46.
46. Sari Y, Franklin KM, Alazizi A et al. (2013) Effects of ceftriaxone on the acquisition and maintenance of ethanol drinking in peri-adolescent and adult female alcohol-preferring (P) rats. Neuroscience 241:229-38.
47. Singh AK, Jiang Y, Benlhabib E et al. (2007) Herbal mixtures consisting of puerarin and either polyenylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in P rats receiving free choice water and 15% ethanol in pure water. J Med Food 10:526-42.
48. Sondheimer I, Knackstedt LA. (2011) Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue-and cocaine-primed reinstatement of cocaine-seeking. Behav Brain Res 225:252-8.
49. Trantham-Davidson H, LaLumiere RT, Reissner KJ et al. (2012) Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training. J Neurosci 32:12406-10.
50. Trinchieri G. (2007) Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 204:239-43.
51. Ye L, Huang Y, Zhao L et al. (2013) IL-1beta and TNF-alpha induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem 125:897-908.
52. Zhou JY, Jiang ZA, Zhao CY et al. (2013) Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver. Alcohol Clin Exp Res 37:213-22.
53. Zou JY, Crews FT. (2005) TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res 1034:11-24.